MACROGENICS INC - 8-K Filing
MacroGenics updates corporate presentation with clinical program details and reports $288M in cash equivalents as of September 30, 2026. (Items: 7.01 of this Current Report on 8-K (including Exhibit 99)
Tickers: $MGNX
MacroGenics updates corporate presentation with clinical program details and reports $288M in cash equivalents as of September 30, 2026. (Items: 7.01 of this Current Report on 8-K (including Exhibit 99)
Tickers: $MGNX